Boston— Newmark Knight Frank announced that it recently completed a 14,764-square-foot lease to KabaFusion at 80 Hayden Avenue in Lexington, Massachusetts on behalf of the property owner, Marwick Associates.
80 Hayden Avenue is a 43,208-square-foot, three-story office building. The most recent lease completed at 80 Hayden Avenue was signed by KabaFusion to serve as a new eastern headquarters location for the firm. Founded in 2010, KabaFusion is a patient-focused, pharmacist-owned home infusion company specializing in IVIG, SCIG and acute therapies.
The company is relocating its east headquarters from 318 Bear Hill Road in Waltham, Massachusetts, where it leased 3,500 square feet. NKF Executive Managing Director Mark Roth, Managing Director Matt Malatesta, Director Brendan Daly and Associate Brianna Piacitelli represented ownership in the lease negotiations. Jack Whelan and Michael O’Leary of Cushman & Wakefield represented KabaFusion.
“We are pleased to have represented Marwick Associates in this lease transaction,” said Roth. “KabaFusion is a great addition to the large life science cluster at Route 2 and I-95. This life science cluster, on the Lexington and Waltham border, now has over two million square feet occupied by companies such as Takeda Pharmaceuticals, Concert Pharmaceuticals, ElevateBio, and Dicerna Pharmaceuticals.”
Founded in the late 1980’s, Marwick Associates is a privately held real estate investment and development firm based in Lexington, MA that owns, manages, and develops office, industrial, and retail properties.
